✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Gan & Lee Pharmaceuticals

Country
China (Mainland)
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
5,309
Ticker
603087
Exchange
Shanghai Stock Exchange
Description
Gan & Lee Pharmaceuticals Inc. is a biopharmaceutical company that engages in the development, manufacture, and commercialization of insulin-related therapeutic products. The company's primary focus i...

Gan & Lee Pharmaceuticals's Revenues Data

Explore Gan & Lee Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
578,808,672a
CN¥4,052 million
417,279,525a
CN¥3,045 million
366,967,360a
CN¥2,608 million
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Gan & Lee Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Gan & Lee Pharmaceuticals's Annual Report 2025